Olwen Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -48.42%
(FY 2023)
- Profit 78.83%
(FY 2023)
- Ebitda -14.52%
(FY 2023)
- Net Worth 17.15%
(FY 2023)
- Total Assets -29.81%
(FY 2023)
About Olwen Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Prajapat and Swati Prajapat serve as directors at the Company.
- CIN/LLPIN
U24232GJ2014PTC080876
- Company No.
080876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Olwen Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Prajapat  | Director | 20-Dec-2014 | Current |
| Swati Prajapat | Director | 20-Dec-2014 | Current |
Financial Performance of Olwen Lifesciences.
Olwen Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.42% decrease. The company also saw a substantial improvement in profitability, with a 78.83% increase in profit. The company's net worth Soared by an impressive increase of 17.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olwen Lifesciences?
In 2023, Olwen Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Olwen Pharmaceuticals Private LimitedActive 2 years 10 monthsRam Prajapat and Swati Prajapat are mutual person
- Bhaskar Green Energy Private LimitedActive 2 years 3 months
Ram Prajapat and Swati Prajapat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Olwen Lifesciences?
Olwen Lifesciences has a workforce of 31 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olwen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olwen Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
